MEASLES, MUMPS, AND RUBELLA ANTIBODIES IN CHILDREN 5-6 YEARS AFTER IMMUNIZATION - EFFECT OF VACCINE TYPE AND AGE AT VACCINATION

被引:58
作者
BOULIANNE, N
DESERRES, G
RATNAM, S
WARD, BJ
JOLY, JR
DUVAL, B
机构
[1] LEONARD A MILLER CTR HLTH SERV,NEWFOUNDLAND PUBL HLTH LAB,ST JOHNS,NF A1B 3T2,CANADA
[2] MCGILL UNIV,MONTREAL GEN HOSP,CTR STUDY HOST RESISTANCE,MONTREAL,PQ H3G 1A4,CANADA
[3] UNIV LAVAL,RECH EPIDEMIOL GRP,QUEBEC CITY,PQ G1S 4L8,CANADA
[4] UNIV LAVAL,HOP ST SACREMENT,DEPT SOCIAL & PREVENT MED,QUEBEC CITY,PQ G1S 4L8,CANADA
关键词
MEASLES; MUMPS; RUBELLA; ANTIBODY PREVALENCE; VACCINE; SEROLOGY;
D O I
10.1016/0264-410X(95)00098-L
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The levels of antibody against measles, mumps, and rubella were determined at 5-6 years postimmunization in 468 children vaccinated with two different trivalent vaccines. The proportions of children without detectable antibody levels were 12 and 3.6% for measles (p<0.001), 14.9 and 7% for mumps (p=0.006), and 3.3 and 3.1% for rubella (p=0.88), respectively, in MMR(R) II and Trivirix(R) recipients. A higher proportion of those vaccinated at younger ages had undetectable or low levels of measles antibody. These data indicate that a large proportion of children vaccinated under routine conditions do not have detectable measles and mumps antibody.
引用
收藏
页码:1611 / 1616
页数:6
相关论文
共 27 条
  • [1] PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE
    ALBRECHT, P
    ENNIS, FA
    SALTZMAN, EJ
    KRUGMAN, S
    [J]. JOURNAL OF PEDIATRICS, 1977, 91 (05) : 715 - 718
  • [2] INTERFERENCE BETWEEN STRAINS IN LIVE VIRUS-VACCINES .1. COMBINED VACCINATION WITH MEASLES, MUMPS AND RUBELLA VACCINE
    BERGER, R
    JUST, M
    GLUCK, R
    [J]. JOURNAL OF BIOLOGICAL STANDARDIZATION, 1988, 16 (04): : 269 - 273
  • [3] SUSTAINED TRANSMISSION OF MUMPS IN A HIGHLY VACCINATED POPULATION - ASSESSMENT OF PRIMARY VACCINE FAILURE AND WANING VACCINE-INDUCED IMMUNITY
    BRISS, PA
    FEHRS, LJ
    PARKER, RA
    WRIGHT, PF
    SANNELLA, EC
    HUTCHESON, RH
    SCHAFFNER, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) : 77 - 82
  • [4] MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS
    CHEN, RT
    MARKOWITZ, LE
    ALBRECHT, P
    STEWART, JA
    MOFENSON, LM
    PREBLUD, SR
    ORENSTEIN, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) : 1036 - 1042
  • [5] DESERRES G, 1995, IN PRESS EPIDEMIOL I
  • [6] FURESZ J, 1988, CAN MED ASSOC J, V138, P135
  • [7] MEASLES OUTBREAK IN A FULLY IMMUNIZED SECONDARY-SCHOOL POPULATION
    GUSTAFSON, TL
    LIEVENS, AW
    BRUNELL, PA
    MOELLENBERG, RG
    BUTTERY, CMG
    SEHULSTER, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) : 771 - 774
  • [8] MUMPS OUTBREAK IN A HIGHLY VACCINATED POPULATION
    HERSH, BS
    FINE, PEM
    KENT, WK
    COCHI, SL
    KAHN, LH
    ZELL, ER
    HAYS, PL
    WOOD, CL
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (02) : 187 - 193
  • [9] KRUGMAN S, 1983, REV INFECT DIS, V5, P477
  • [10] LAVERGNE B, 1986, CAN DIS WEEKLY REP, V12, P85